A properly functioning immune system is dependent on programmed cell death / apoptosis at virtually every stage of lymphocyte development and activity. Carbon monoxide (CO), an enzymatic product of heme oxyenase-1 (HO-1), has been shown to possess anti-apoptotic effects in a number of different model systems. The purpose of the present study was to expand on this knowledge to determine the role of CO in the wellestablished model of Fas/CD95 induced apoptosis in Jurkat cells, and to determine the mechanism by which CO can modulate T cell apoptosis. Exposure of Jurkat cells to CO resulted in augmentation in Fas/CD95 induced apoptosis, which correlated with COinduced up-regulation of the pro-apoptotic protein FADD as well as activation of caspases 8, 9, and 3 while simultaneously down-regulating the anti-apoptotic protein Bcl-2. These effects of CO were lost with overexpression of FADD siRNA. CO, as previously demonstrated in endothelial cells, was also anti-apoptotic in Jurkat cells against TNF and etoposide. We further demonstrate that this pro-apoptotic effect of CO was independent of reactive oxygen species (ROS) production and involved inhibition in Fas/CD95-induced activation of the pro-survival ERK MAP kinase. We conclude, that in contrast to other studies showing the anti-apoptotic effects of CO, Fas/CD95-induced cell death in Jurkat cells is augmented by exposure to CO and that this occurs in part via inhibition in the activation of ERK MAP kinase. These data begin to elucidate specific differences with regard to the effects of CO and cell death pathways and provide important and valuable insight into potential mechanisms of action.
Introduction
The balance of lymphocyte proliferation and death is crucial in lymphocyte homeostasis. A properly functioning immune system is dependent on programmed cell death at virtually every stage of lymphocyte development. Apoptosis is an evolutionarily conserved and highly controlled form of cell death that plays a crucial role in development, maintenance of homeostasis, and immunological responses in multicellular organisms. Dysregulation of apoptosis is implicated in a range of diseases, including cancer, neurodegenerative disorders and autoimmune diseases (1) . Fas/CD95 mediated apoptosis plays a pivotal role in a number of physiological processes and seems to be particularly important for immune function (2) . For example, promoting Fas/CD95 induced apoptosis could be one possible therapeutic approach to induce tolerance against a transplanted organ, autoimmune disorders or cancer. In fact, clinical trials are underway looking at site-directed delivery of death receptor ligands as a potential therapeutic strategy.
Heme oxygenases are the rate-limiting enzymes in heme degradation, catalyzing the cleavage of the heme ring releasing ferrous iron, carbon monoxide (CO) and biliverdin (3) . The induction of HO-1 occurs as an adaptive and protective response to various tissue and cellular injury models including sepsis, hyperoxia, hypoxia, and other oxidant-induced tissue damage (3, 4) . Furthermore, expression of HO-1 in rodent liver, heart and kidney allografts (5) (6) (7) (8) and heart xenografts (9) correlates with long-term graft survival. Recent attention has focused on the biological effects of these products of this enzymatic reaction, which have been shown to impart important cytoprotective functions (9) (10) (11) . One of the products, carbon monoxide (CO) is a gas molecule historically by guest on December 31, 2017 http://www.jbc.org/ Downloaded from associated with toxicity and lethality to organisms exposed to industrial doses. However, against this known paradigm of CO toxicity, there has been renewed interest in recent years in CO behaving as a signaling molecule in many cellular and biological processes (12) (13) (14) (15) (16) (17) . Exogenous CO has been shown to have potent anti-inflammatory and antiproliferative effects (18) (19) (20) (21) .
The role of CO in relation to apoptosis has been intensively studied. The antiapoptotic effect of CO has been shown in vitro in endothelial cells, fibroblasts and hepatocytes as well as in vivo in models of lung and small intestinal ischemia-reperfusion injury (11, (22) (23) (24) (25) (26) . In a mouse-to-rat cardiac xenotransplant model, exogenous CO suppressed graft rejection and restored long-term graft survival (27) . This effect of CO was associated partially with the inhibition of apoptosis of endothelial cells.
The present study was initially designed to further our understanding of the mechanism(s) by which CO exerts cytoprotective and anti-apoptotic effects. We chose a variety of apoptosis-inducing agents using Jurkat cells to study apoptosis to see if we could identify potential cellular targets of CO. To do this, we chose both ligand dependent and independent pathways by which to induce cell death. In all situations tested including serum starvation, UV irradiation, etoposide, TNF-α and camptothecininduced cell death, CO was equally cytoprotective. However, when we tested the effects of CO on Fas/CD95 and TRAIL-induced cell death we found a profound difference; CO augmented cell death.
The mitogen activated protein kinase (MAPK) pathways have been implicated in

Annexin V / Propidium Iodide Staining
Using the annexin V-FITC kit from BD Pharmingen (San Diego, CA), we followed the manufacturer's protocol. Briefly, cells were washed with cold PBS and resuspended with binding buffer (10 mM HEPES/NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl 2 ) before transferring 1 x 10 5 cells to a 5-ml tube. Annexin V and propidium iodide were added to the cell preparations, and incubated for 25 min in the dark. Binding buffer (400 µl) was then added to each tube and the samples were analyzed by flow cytometry.
Caspase Activity Assay
For caspase activity assay, cells were washed in PBS and lysed by freeze-thaw in buffer A (20mM HEPES, 10 mM KCL, 1.5mM MgCl2, 1mM EDTA, 1mMEGTA). Cell lysates were obtained from supernatants after a 30-minute centrifugation at 13000 rpm at 
FADD siRNA and Transfection
siRNA for FADD was designed and synthesized as previously described (28) . The Specific cDNA inserts against human FADD MAPKs were designed and cloned into expression vector system (pSUPER) that directs the synthesis of small interfering RNAs (siRNAs) in mammalian cells, under the control of the polymerase III promoter. The specific cDNAs were such that they specify a 19-nucleotide sequence against the desired gene, i.e. FADD and was separated by a stretch of 9 nucleotide from the reverse complement of the same 19 nucleotide sequence. At the 5' and 3' ends restriction sites for cloning into pSUPER were included. These inserts identical to those previously published (28) . Inhibition of FADD protein expression was assessed by immunoblot analysis following transfection of Jurkat cells with FADD-siRNA. Non-targeting siRNA was purchased from Dharmacon (Lafayette, CO) as control for non-sequence-specific effects. Briefly, Jurkat cells were grown in 24 well plates and transiently transfected with 1.5ug and 3ug of siRNA mixed with Lipofectamine 2000 according to manufacturer's protocol. After incubation at 37 °C, 5% CO 2 for 48 hours, the cells were treated with Fas/CD95 in the presence and absence of 250ppm CO. Samples were then prepared and analyzed for apoptosis or immunoblotting.
Bcl-2 Adenovirus Infection
Bcl-2 adenovirus and control (empty cassette) virus was used as previously described (29) . Briefly, 1 x 10 6 / Jurkat cells were cultured in 24 well plates and exposed to 1x 
Cell extracts and Western Blot Analysis
Cells were harvested via first rinsing in ice cold PBS and then immediately resuspended in cell lysis buffer containing a complete protease inhibitor cocktail (New England Biolabs, Beverly, MA). Cellular protein extracts were electrophoresed under denaturing conditions (10-12.5% polyacrylamide gels) and transferred onto nitrocellulose membranes (BioRad, Hercules, CA). Caspase 3, 8 and 9 were detected using rabbit antihuman polyclonal antibody (Stressgen, Victoria, BC, Canada). Bcl-2, Fas, HSP70, IAP and FADD were detected using mouse anti-human polyclonal antibody (Santa Cruz Biotel, CA). β-actin was detected using mouse anti-human β-actin monoclonal antibody (Sigma Chemical Co. St. Louis, MO). Total and activated / phosphorylated forms of ERK were detected using rabbit polyclonal antibodies directed against the total phosphorylated form of ERK, according to the manufacturer's suggestions (New England Biolabs Inc., Beverly, MA). Phosphorylated ERK were normalized to the total amount of ERK, detected in the same membrane. Primary antibodies were detected using horseradish peroxidase conjugated donkey anti-rabbit or anti-mouse IgG secondary antibodies (Pierce, Rockford, IL, USA). Peroxidase was visualized using the Enhanced ChemiLuminescence assay (Amersham Life Science Inc., Arlington Heights, IL) according to manufacturer's instructions. When indicated, membranes were stripped (62.5 mM Tris-HCI, pH 6.8, 2% SDS and 100 mM P-mercaptoethanol, 30 minutes, 50°C).
Statistical Analysis
Data are expressed as the mean + SE. Differences in measured variables between experimental and control group were assessed using Student's t tests. Statistical calculations were performed on a Macintosh personal computer using the Statview II
Results
Carbon monoxide inhibits Etoposide induced apoptosis but promotes Fas/CD95 and TRAIL-induced apoptosis.
Jurkat cells were pretreated with 250ppm CO for 2 hours and then treated with Etoposide (100µM), Fas/CD95 (500ng/ml) or TRAIL (100ng/ml) for 6 hours. Apoptosis was assessed by flow cytometry. Etoposide-induced apoptosis was inhibited by CO. CO also inhibited Camptothecin, UV irradiation, serum starvation and TNF-α/Actinomicin D-induced apoptosis (data not shown). CO exposure increased Fas/CD95 and TRAILinduced apoptosis (Fig 1A) . In accord with these stimuli-specific effects of CO, bcl-2, an anti-apoptotic protein, was up-regulated by CO in the presence of Etoposide as would be expected in cells that are protected, while cells treated with either Fas/CD95 or TRAIL showed decreased bcl-2 expression in the presence of CO (Fig 1B) . In the presence of 250 ppm CO, Fas/CD95 induced apoptosis was strongly promoted, as assessed by Annexin/PI staining and analyzed by flow cytometry (Fig 2A) . The amplification in the number of apoptotic cells by CO in the presence of Fas/CD95 was due to the induction of cell death in live cells and not via increasing the proportion of necrotic cells (Fig 2B) .
Exposure to CO alone without stimulation had no effects on cell death. We observed similar effects of CO on Fas/CD95-induced death of a lung cancer cell line (data not shown).
Carbon monoxide up-regulates pro-apoptotic proteins FADD, caspase 8, 9 and 3 which are necessary for enhanced cell death by Fas/CD95.
FADD and Caspase 8 are among the earliest proteins involved in the ligand dependent apoptotic pathways. We observed that FADD was strongly induced by CO at both 1 and 6 hours after Fas/CD95 stimulation (Fig 3A) . One hour after Fas/CD95 stimulation, caspase 8 activity and cleavage were increased in the presence of CO, which was confirmed by western blot analysis (Fig 3B) . Similar to FADD, activation of caspases 8, 9 and 3 were also observed by CO at both 1 and 6 hours after Fas/CD95 stimulation as assessed by western blot analysis (Fig 4) . In agreement with the caspase data, we found that the anti-apoptotic protein bcl-2 was significantly down-regulated by CO (Fig 4) . Due to the increased FADD expression observed in the CO-treated cells, we next tested whether the increased FADD expression was necessary for the CO effects. To test this, we developed an expression vector specific for FADD siRNA. Transient overexpression of FADD siRNA resulted in a specific and significant decrease in FADD expression (Fig 5A) . To test whether expression of the siRNA had functional consequences, we transfected Jurkats and then treated with Fas/CD95 in the presence and absence of CO and observed that the increased expression of FADD was required for the CO-induced augmentation (Fig 5B) . We next evaluated whether inhibition of the caspases which are downstream death effectors would also interfere with the CO-induced enhancement of cell death following Fas/CD95 stimulation. Jurkat cells treated with the select chemical inhibitors of caspase 3, 8 and 9 prior to CO/Fas treatment showed that treatment with these inhibitors prevented Fas/CD95 killing as well as the enhanced CO effects on cell death (Fig 6) . Conclusions from these findings supported the concept that CO is selective in its effects requiring the specific activation of the FADD/caspase cascades and were not merely a broad non-selective effect of CO on cell death following stimulation with Fas/CD95.
with Fas/CD95.
Bcl-2 expression correlates with cell survival. Exposure to Fas/CD95 results in decreased expression of bcl-2 and is a hallmark signal of the death pathways. Treatment of Jurkats with Fas/CD95 in the presence of CO showed an amplified reduction in bcl-2 supporting the pro-apoptotic actions of CO in this model of cell death. To confirm that this decrease in bcl-2 was specific to the developing paradigm of CO in this model, we overexpressed bcl-2 using adenoviral infection. Figure 7 shows that bcl-2 overexpression was effective at preventing Fas/CD95-induced cell death and as expected significantly prevented the ability of CO to augment death. CO in the presence of bcl-2 overexpression still showed increased death versus air controls treated with ad-bcl-2 which suggests an additional FADD/caspase-dependent pathway by which CO is inducing death. This would fit the bcl-2 immunoblot in Fig 1B where CO was not able to completely inhibit bcl-2 expression while augmenting cell death. Of note, adenoviral overexpression of bcl-2 in certain situations results in increased cell death. We performed dose response curves with the adenovirus and at 10 and 100 fold higher viral concentrations, we noted that the cells exhibited an increased amount of cell death due to the heightened bcl-2 expression which has been observed by others (personal communication).
The effects of CO occurred independently of Fas/CD95 receptor modulation.
We evaluated whether the CO effect on Fas/CD95 induced apoptosis was simply dependent on the regulation of Fas/CD95 receptor expression on the cell surface. We demonstrate that CO did not change receptor levels as assessed by both western blot 
Effect of CO on HSP70 and IAP expression in the presence of Fas/CD95.
Heat shock proteins (HSP's) were first described as a set of proteins the expression of which was induced by heat stress. Recent evidence suggests that HSPs can play a role in apoptosis (30) . Western blot analysis of HSP70 expression showed no effect of CO or Fas/CD95 treatment (Fig 8) , indicating that the pro-apoptotic effect of CO in Fas/CD95-stimulated cells is independent of HSP 70.
We also studied the effect of CO on the inhibitor of apoptosis protein (IAP).
Fas/CD95 (Fig 8) , as expected, resulted in a rapid decrease by 6 hr of IAP, which was unchanged in the presence of CO at the time points tested. It is possible that a more rapid loss of IAP might be observed at a time point earlier then 6 h or alternatively that in this system, IAP is not involved in the effects observed with CO.
The pro-apoptotic effect of CO in Fas/CD95-treated cells does not involve increased ROS production.
CO has been shown to possess both pro-and anti-oxidant effects depending on the situation (31). Thom et al. showed that CO in EC could also be pro-apoptotic and that this was due to increased generation of reactive oxygen species (32) . Others have shown that exposure to CO results in an increase in the anti-oxidant reducing capacity of the cell (31). We hypothesized that CO in this model of Fas/CD95-induced cell death was acting via such a mechanism and increasing the generation of ROS by the Jurkat cells. To test this hypothesis, we used the well-described antioxidant N-acetyl-cysteine (NAC), which was administered to the cells prior to the exposure to CO. As a positive control for NAC, we treated cells with etoposide and showed that apoptosis was significantly reduced (Fig   9) . Similar results were observed with TNF-α-induced cell death, i.e. stimulation with TNF-α in the presence of NAC prevented/suppressed cell death (data not shown). In contrast, cells treated with NAC and Fas/CD95 in the presence of CO showed no diminution of cell death (Fig 9) . We conclude from these data that the effects of CO on Fas/CD95-induced death do not involve an increased production of ROS, at least under the conditions tested.
The pro-apoptotic effect of CO with Fas/CD95 treatment may be dependent on inhibition of the ERK MAPK pathway.
ERK MAPK has been shown to provide cytoprotection against Fas/CD95-induced apoptosis in Jurkat cells (33) . Following administration of UO126, a selective inhibitor of MEK1/MEK2, the upstream kinases responsible for the activation of ERK Fas/CD95 induced apoptosis in Jurkat cells was increased (Fig 10A) , confirming a protective role for ERK activation. CO markedly inhibited Fas/CD95-induced ERK phosphorylation at both the 15 and 30 minute time points (Fig 10B) , suggesting that the pro-apoptotic effect of CO in cells treated with Fas/CD95 in part is dependent on inhibition of the ERK MAPK pathway. Of note, the effects of CO were independent of the JNK and p38 MAP kinase pathways (data not shown).
Discussion
These results demonstrate that a low concentration of CO can enhance cell death in response to Fas/CD95 stimulation in Jurkat cells. In addition these effects are stimulispecific as treatment with CO in the presence of other death-inducing stimuli showed potent protection against death in the same Jurkat cell line. While the precise cellular and molecular target that specifies these differences remains unclear, the effects of CO do not involve increased generation of reactive oxygen species, but rather decreased activation of ERK MAPK, a pro-survival signaling pathway.
Apoptosis-inducing signals can be divided into two main groups: (a) those that lead to the formation of a death-inducing signaling complex at the cytoplasmic side of death receptors, resulting in the direct activation of a cascade of proteolytic caspases responsible for cell death, and (b) those that initially lead to the release of apoptogenic molecules from the mitochondria, i.e. cytochrome c (33) . In certain cell types, however, even death receptor-initiated apoptotic signals may be dependent on the mitochondria to induce cell death (34) . The Jurkat cell falls into this category and is perhaps the most well characterized and prototypic of all cell types studied, particularly with regard to ligation of the Fas/CD95 death receptor. This mode of cell death can be inhibited by interference with the pro-apoptotic mitochondrial changes (35) (36) .
Carbon monoxide (CO) is now emerging as an important signaling and regulatory molecule in a multitude of cellular and biological processes (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) . Exogenous CO has been shown to have potent anti-inflammatory and anti-proliferation effects in vitro and in vivo (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) .
One field of interest that has attracted a number of investigations is the ability of CO to modulate cell death. Most have reported that CO exposure evokes potent antiapoptotic effects against a number of inducing agents. Additionally, CO has been shown to prevent heart, lung and small intestinal ischemia-reperfusion injury as it relates to organ transplantation, in part by interfering with endothelial cell death (11, 27) . The field is complicated by reports that CO can induce cell death (31); it appears as though the cell type and model system are important in the varying effects. Others and we have shown that CO is anti-apoptotic in fibroblasts, endothelial cells and hepatocytes, but the precise cellular targets by which CO exerts these effects remain unclear. We know that CO utilizes both the p38 MAPK and NF-κB signaling cascades and attenuates caspase 3 activity to exert anti-apoptotic effects (22) (23) . However, neither of these pathways contains a heme-containing protein moiety that would be a logical target for CO.
In an effort to better elucidate cellular mechanisms, we utilized Jurkat cells. Our approach was to utilize well described inducers of cell death that kill via different modes of action to identify novel differences in the effects observed with CO. In this present study, we first demonstrated that CO prevented etoposide, camptothecin, UV, serum starvation and TNF-α/Actinomicin D induced apoptosis. In contrast, we found that when cell death was induced by addition of the ligands Fas/CD95 or TRAIL, CO augmented apoptosis. We conclude from these data that CO is pro-apoptotic when the death receptor pathway is playing the major role, and CO is anti-apoptotic when the mitochondrial pathway is dominant. We substantiated these results using numerous cell markers, If the balance of oxidants to anti-oxidants shifts towards a pro-oxidant state, the cell can become overwhelmed and initiate the apoptotic machinery. One of the hallmarks of ischemia/reperfusion injury of organs is the burst of free radical formation that rapidly ensues following reperfusion leading to damaged cellular proteins, lipids and nucleic acids. If the anti-oxidant systems cannot compensate, the cell will die leading to tissue damage and ultimately organ failure. Numerous studies have shown that increasing the amount of anti-oxidant enzymes or adding vitamin E or similar substances can limit the tissue damage. In vitro, similar results have also been demonstrated using agents such as N-acteyl-cysteine (NAC), Trolox, or superoxide dismutase mimetics to name a few. We hypothesized that if CO was interfering with mitochondrial electron transport or other systems such as NADPH oxidase, it might be increasing the production of ROS that in the T-cell might predispose the cell to selective killing by Fas/CD95. We therefore added NAC to both TNF and Fas/CD95 treated cells and as has previously been shown (37), NAC prevented etoposide-induced cell death regardless of CO, while NAC had no effect on Fas/CD95-induced death in the presence of CO. We concluded from these studies that CO was not increasing ROS to act synergistically or additively in augmenting Fas/CD95 killing. We therefore explored other potential cellular targets. The majority of the reports cite the MAP kinases as being intimately involved in the effects observed with CO.
Studies have shown that inhibition of MAPK signaling markedly sensitized the cells to Fas/CD95-mediated apoptosis (38) . We have shown that CO signals antiinflammatory and anti-apoptotic effects via the p38 MAPK pathway. Moreover, CO inhibits human airway smooth muscle proliferation via inhibition of the ERK1/ERK2 MAPK pathway. CO also prevents the activation of c-Jun NH2 terminal kinase (JNK) phosphorylation in RAW 264.7 cells as well as in murine lung endothelial cells (39) .
We hypothesized that CO was interfering with ERK1/ERK2 activation which was then leading to amplification of Fas/CD95-induced death. In the current study, we confirmed that inhibition of MAPK/ERK with UO126 markedly sensitized the Jurkat cells to Fas/CD95-mediated apoptosis (Fig 10A) , which paralleled our observations with CO to this point. We then measured the effect of CO on the activation of ERK by Fas/CD95. At both 15 and 30 minutes, CO significantly inhibited Fas/CD95-induced ERK phosphorylation (Fig 10B) , suggesting that this pathway at least in part explains one mechanism by which CO promotes Fas/CD95-mediated apoptosis.
These studies have not identified the cellular target for CO as the ERK MAP kinase does not contain a heme group which would be a prototypical target for CO.
However, the results provide a further separation of the cellular pathways involved and significantly narrow the field of potential candidate targets.
In conclusion, we present a series of data that further heighten out understanding of the effects of CO in modulating cell death, but in addition we outline important findings that might explain in part some of the in vivo findings, in particular those studies involving ischemia/reperfusion injury and organ rejection following transplantation. (500ng/ml) treatment in the presence or absence of 250 ppm CO were assessed for activated caspase 9 and caspase 3 and bcl-2 by western blot as described in Methods.
Note the time-dependent increase in the cleavage products of caspase 3 and 9, which is indicative of increased activity. β-actin was used as normalization control. Data shown is representative blot from 3 independent experiments. 
